Troy Lister

Corporate Officer/Principal en

American Chemical Society

46 años

91 relaciones

Health Technology

Commercial Services

Consumer Services

Perfil

Troy Lister currently works at American Chemical Society, as Member.
Dr. Lister also formerly worked at Spero Therapeutics, Inc., as Senior Vice President-Research & Development from 2014 to 2022 and Verve Therapeutics, Inc., as Chief Scientific Officer from 2024 to 2025.
Dr. Lister received his undergraduate degree and doctorate degree from Flinders University.

Cargos activos de Troy Lister

Empresas	Cargo	Inicio
American Chemical Society American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry	Corporate Officer/Principal	-

Todos los cargos activos de Troy Lister

Antiguos cargos conocidos de Troy Lister.

Empresas	Cargo	Fin
VERE THER	Director Técnico/Científico/I+D	25/07/2025
SPERO THERAPEUTICS, INC.	Director Técnico/Científico/I+D	01/05/2022

Ver el detalle de la experiencia de Troy Lister.

Formación de Troy Lister.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Troy Lister.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
American Chemical Society American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry	Commercial Services
Flinders University Flinders University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Spero Therapeutics, Inc. Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections	Health Technology
Verve Therapeutics, Inc. Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease	Health Technology